Minerva Neurosciences, Inc. (NERV)
4.17
+0.05
(+1.21%)
USD |
NASDAQ |
Sep 10, 16:00
4.17
0.00 (0.00%)
After-Hours: 19:17
Minerva Neurosciences Shareholders Equity (Quarterly) : -213.30M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -213.30M |
| March 31, 2026 | -254.01M |
| December 31, 2025 | -140.75M |
| September 30, 2025 | -34.58M |
| June 30, 2025 | -32.11M |
| March 31, 2025 | -29.15M |
| December 31, 2024 | -25.69M |
| September 30, 2024 | -21.67M |
| June 30, 2024 | -44.49M |
| March 31, 2024 | -36.59M |
| December 31, 2023 | -28.46M |
| September 30, 2023 | -20.05M |
| June 30, 2023 | -12.51M |
| March 31, 2023 | -26.62M |
| December 31, 2022 | -20.02M |
| September 30, 2022 | -14.25M |
| June 30, 2022 | -8.382M |
| March 31, 2022 | -0.7361M |
| December 31, 2021 | 7.976M |
| September 30, 2021 | 28.08M |
| June 30, 2021 | 36.17M |
| March 31, 2021 | 45.37M |
| December 31, 2020 | 52.66M |
| September 30, 2020 | 58.02M |
| June 30, 2020 | 56.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 18.62M |
| December 31, 2019 | 27.78M |
| September 30, 2019 | 55.53M |
| June 30, 2019 | 67.27M |
| March 31, 2019 | 77.42M |
| December 31, 2018 | 90.26M |
| September 30, 2018 | 101.39M |
| June 30, 2018 | 110.66M |
| March 31, 2018 | 121.29M |
| December 31, 2017 | 131.60M |
| September 30, 2017 | 130.18M |
| June 30, 2017 | 98.03M |
| March 31, 2017 | 106.29M |
| December 31, 2016 | 105.98M |
| September 30, 2016 | 113.14M |
| June 30, 2016 | 120.60M |
| March 31, 2016 | 66.65M |
| December 31, 2015 | 55.32M |
| September 30, 2015 | 63.07M |
| June 30, 2015 | 68.38M |
| March 31, 2015 | 74.44M |
| December 31, 2014 | 51.50M |
| September 30, 2014 | 56.72M |
| June 30, 2014 | 29.23M |
| March 31, 2014 | 34.09M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 95.09M |
| Total Liabilities (Quarterly) | 308.39M |
| Debt to Equity Ratio | -0.3363 |
| Current Ratio | 20.14 |
| Net Debt Paydown Yield | -0.90% |